Is LivePerson Stock Heading for a Downturn?

Market participants are bracing for what appears to be another challenging quarterly report from LivePerson. Financial experts project a significant loss per share for the third quarter of 2025, with estimates ranging from -$2.70 to -$3.38. Concurrently, revenue is anticipated to land between $56.84 million and $57.11 million, marking a substantial year-over-year decline.

This bleak outlook continues a negative trend established in the previous quarter. During Q2, the company experienced a 25.4% drop in revenue, which fell to $59.6 million. This performance resulted in a net loss of $15.7 million. A minor bright spot emerged from the sales department, which demonstrated some resilience by securing 38 deals, including three new client acquisitions.

In the face of these financial headwinds, LivePerson is doubling down on its Conversational AI strategy. The company launched its "Conversation Simulator" platform on November 6th, a tool designed to allow businesses to test generative AI solutions without associated risks. This initiative directly addresses corporate concerns regarding AI accuracy and regulatory compliance.

Should investors sell immediately? Or is it worth buying LivePerson?

The company's financial foundation received a boost from a strategic refinanzierung completed on September 15. This transaction successfully reduced outstanding debt by $226 million and extended maturity dates to December 2029. This financial maneuvering was preceded by the appointment of Ryan Vardeman to the board of directors on October 20.

Diverging Views from Market Analysts

Research analysts are presenting a divided front regarding LivePerson's prospects. Recommendations are split, with some maintaining a "Hold" position while others advise clients to "Reduce" their exposure. The consensus price target currently sits at $19.12, though individual forecasts show a wide dispersion from $15.15 to $23.62. It is noteworthy that several analyses from the past twelve months lack specific price targets.

The critical question for investors is whether the equity can recover from its current trading level of $5.62. The stock's 52-week range, which spans from $5.19 to $31.20, illustrates both the latent potential for significant gains and the extreme volatility inherent in this security. The upcoming quarterly earnings release is expected to set the near-term directional course for the share price.